news

Shire plans to acquire Belgian Movetis for €428m

British pharmaceutical company Shire has made an offer to acquire Belgian pharmaceutical company Movetis for 428 million euros (565 million US dollars). Movetis specializes in the development and production of medicines for the treatment of gastrointestinal diseases.

Pfizer Quarterly Sales Up 58%

In the II quarter of 2010, the net profit of the American pharmaceutical company grew by 9% and amounted to 2.47 billion US dollars against 2.26 billion dollars a year earlier. At the same time, earnings per share decreased by 9% to $0.31 compared to $0.34 in the second quarter of 2009.

Sanofi-Aventis may initiate hostile takeover of Genzyme

French pharmaceutical company Sanofi-Aventis SA may initiate a hostile takeover of US biotech company Genzyme Corp. if the management of the latter refuses the acquisition offer, Citgroup Inc. analysts believe. Mark Dainty and Yaron Werber.

FDA Approves Combination Antihypertensive Tribenzor™

On July 26, the Japanese company Daiichi Sankyo Co. Ltd.” announced that the US Food and Drug Administration (FDA) has approved its combination drug Tribenzor™ (olmesartan + amlodipine + hydrochlorothiazide) for the treatment of hypertension in patients whose blood pressure is unresponsive to other combination antihypertensive drugs. means. Daiichi Sankyo notes that Tribenzor simplifies dosing regimens and also …

FDA Approves Combination Antihypertensive Tribenzor™ Read More »

Merck&Co. completed Q2 2010 with a 52% decline in net profit

In the II quarter of 2010, the net profit of the American pharmaceutical company Merck & Co. decreased by 52% due to increased costs, in particular administrative and restructuring, as well as a sharp decrease in profits from partnerships.